Phase 1, placebo-controlled, dose escalation trial of chicory root extract in patients with osteoarthritis of the hip or knee

BMC Musculoskeletal Disorders

Volumn 11, Issue , 2010, Pages

  Olsen, Nancy J ^a,c   Branch, Valerie K ^a   Jonnala, Geetha ^a   Seskar, Mira ^b   Cooper, Melisa ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b Phytomedics Inc   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICORY EXTRACT; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CHICORY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; LABORATORY TEST; MALE; NAUSEA; PHASE 1 CLINICAL TRIAL; PLANT ROOT; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; VITAL SIGN; WALKING; AGED; CHEMISTRY; COHORT ANALYSIS; MIDDLE AGED; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY; PILOT STUDY; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHICORY; COHORT STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; PILOT PROJECTS; PLACEBOS; PLANT EXTRACTS; PLANT ROOTS; TREATMENT OUTCOME;

EID: 77954322447     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-11-156     Document Type: Article

References (18)

1. In the clinic. Osteoarthritis. DJ Hunter, Ann Intern Med 2007 147 TC8-1 ITC8-16
2. Patient characteristics affecting the prognosis of total hip and knee joint arthroplasty: a systematic review. PL Santaguida GA Hawker PL Hudak R Glazier NN Mahomed HJ Kreder PC Coyte JG Wright, Can J Surg 2008 51 428 436 19057730
3. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. T Pincus GG Koch T Sokka J Lefkowith F Wolfe JM Jordan G Luta LF Callahan X Wang T Schwartz SB Abramson JR Caldwell RA Harrell JM Kremer RL Lautzenheiser JA Markenson TJ Schnitzer A Weaver P Cummins A Wilson S Morant J Fort, Arthritis Rheum 2001 44 1587 1598 10.1002/1529-0131(200107)44:7<1587::AID-ART282>3. 0.CO;2-X 11465710
4. New horizons and perspectives in the treatment of osteoarthritis. F Berenbaum, Arthritis Res Ther 2008 10 Suppl 2 1 10.1186/ar2462 19007426
5. Cardiovascular toxicity of valdecoxib. WA Ray MR Griffin CM Stein, N Engl J Med 2004 351 2767 10.1056/NEJMc045711 15608086
6. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. DO Clegg DJ Reda CL Harris MA Klein JR O'Dell MM Hooper JD Bradley CO Bingham MH Weisman CG Jackson NE Lane JJ Cush LW Moreland HR Schumacher Jr CV Oddis F Wolfe JA Molitor DE Yocum TJ Schnitzer DE Furst AD Sawitzke H Shi KD Brandt RW Moskowitz HJ Williams, N Engl J Med 2006 354 795 808 10.1056/NEJMoa052771 16495392
7. Nutraceutical therapies for degenerative joint diseases: a critical review. R Goggs A Vaughan-Thomas PD Clegg SD Carter JF Innes A Mobasheri M Shakibaei W Schwab CA Bondy, Crit Rev Food Sci Nutr 2005 45 145 164 10.1080/10408690590956341 16048146
8. The relationship between chondroprotective and antiinflammatory effects of Withania somnifera root and glucosamine sulphate on human osteoarthritic cartilage in vitro. VN Sumantran R Chandwaskar AK Joshi S Boddul B Patwardhan A Chopra UV Wagh, Phytother Res 2008 22 1342 1348 10.1002/ptr.2498 18697233
9. Inhibition of the expression and activity of cyclooxygenase-2 by chicory extract. C Cavin M Delannoy A Malnoe E Debefve A Touche D Courtois B Schilter, Biochem Biophys Res Commun 2005 32 742 749 10.1016/j.bbrc.2004.12.061
10. Toxicological evaluation of a chicory root extract. BM Schmidt N Ilic A Poulev I Raskin, Food Chem Toxicol 2007 45 1131 1139 10.1016/j.fct.2006.12.019 17306431
11. WOMAC: a 20-year experiential review of a patient-centered self-reported health status questionnaire. N Bellamy, J Rheumatol 2002 29 2473 2476 12465137
12. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. S McConnell P Kolopack AM Davis, Arthritis Rheum 2001 45 453 461 10.1002/1529-0131(200110)45: 5<453::AID-ART365>3.0.CO;2-W 11642645
13. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. S Keller CM Bann SL Dodd J Schein TR Mendoza CS Cleeland, Clin J Pain 2004 20 309 318 10.1097/00002508-200409000-00005 15322437
14. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. T Pincus JA Summey SA Soraci KA Wallston Jr NP Hummon, Arthritis Rheum 1983 26 1346 1353 10.1002/art. 1780261107 6639693
15. New pain guideline for older patients: avoid NSAIDs, consider opioids. BM Kuehn, JAMA 2009 302 19 10.1001/jama.2009.887 19567426
16. Acetaminophen hepatotoxicity and acute liver failure. LJ Chun MJ Tong RW Busuttil JR Hiatt, J Clin Gastroenterol 2009 43 342 349 10.1097/MCG. 0b013e31818a3854 19169150
17. Natural products as a gold mine for arthritis treatment. D Khanna G Sethi KS Ahn MK Pandey AB Kunnumakkara B Sung A Aggarwal BB Aggarwal, Curr Opin Pharmacol 2007 7 344 351 10.1016/j.coph.2007.03.002 17475558
18. Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. LG Ameye WS Chee, Arthritis Res Ther 2006 8 127 10.1186/ar2016 16859534